Marshall Wace’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11M | Buy |
+742,725
| New | +$11M | 0.01% | 730 |
|
2024
Q4 | – | Sell |
-111,341
| Closed | -$1.56M | – | 2811 |
|
2024
Q3 | $1.56M | Buy |
+111,341
| New | +$1.56M | ﹤0.01% | 1348 |
|
2023
Q4 | – | Sell |
-73,332
| Closed | -$656K | – | 2298 |
|
2023
Q3 | $656K | Buy |
+73,332
| New | +$656K | ﹤0.01% | 1372 |
|
2023
Q2 | – | Sell |
-214,498
| Closed | -$4.82M | – | 2514 |
|
2023
Q1 | $4.82M | Buy |
+214,498
| New | +$4.82M | 0.01% | 860 |
|
2022
Q1 | – | Sell |
-6,866
| Closed | -$213K | – | 3329 |
|
2021
Q4 | $213K | Sell |
6,866
-45,441
| -87% | -$1.41M | ﹤0.01% | 2462 |
|
2021
Q3 | $1.27M | Buy |
+52,307
| New | +$1.27M | 0.01% | 1442 |
|
2021
Q2 | – | Sell |
-174,193
| Closed | -$4.35M | – | 2565 |
|
2021
Q1 | $4.35M | Buy |
+174,193
| New | +$4.35M | 0.02% | 822 |
|
2020
Q3 | – | Sell |
-98,976
| Closed | -$2.02M | – | 1892 |
|
2020
Q2 | $2.02M | Buy |
+98,976
| New | +$2.02M | 0.01% | 768 |
|
2016
Q3 | – | Sell |
-90,194
| Closed | -$1.61M | – | 1134 |
|
2016
Q2 | $1.61M | Buy |
90,194
+71,952
| +394% | +$1.28M | 0.01% | 620 |
|
2016
Q1 | $249K | Buy |
+18,242
| New | +$249K | ﹤0.01% | 950 |
|